FWM
UTHR icon

Frontier Wealth Management’s United Therapeutics UTHR Stock Holding History

Frontier Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,650
Closed -$211K – 324
2019
Q3 		$211K Sell
2,650
-2,000
-43% -$161K 0.03% 278
2019
Q2 		$363K Hold
4,650
– – 0.05% 223
2019
Q1 		$546K Sell
4,650
-14
-0.3% -$1.63K 0.07% 204
2018
Q4 		$508K Buy
4,664
+9
+0.2% +$1.04K 0.08% 202
2018
Q3 		$595K Hold
4,655
– – 0.06% 203
2018
Q2 		$527K Buy
4,655
+5
+0.1% +$550 0.08% 211
2018
Q1 		$522K Buy
4,650
+1,000
+27% +$127K 0.07% 224
2017
Q4 		$540K Hold
3,650
– – 0.09% 201
2017
Q3 		$428K Hold
3,650
– – 0.06% 252
2017
Q2 		$474K Hold
3,650
– – 0.07% 231
2017
Q1 		$494K Hold
3,650
– – 0.08% 229
2016
Q4 		$524K Buy
3,650
+1,500
+70% +$192K 0.09% 211
2016
Q3 		$254K Buy
+2,150
New +$258K 0.04% 312
2016
Q2 		– Sell
-2,533
Closed -$282K – 362
2016
Q1 		$282K Sell
2,533
-343
-12% -$43.4K 0.02% 262
2015
Q4 		$450K Sell
2,876
-788
-22% -$115K 0.07% 211
2015
Q3 		$481K Sell
3,664
-50
-1% -$8.02K 0.08% 212
2015
Q2 		$646K Buy
3,714
+194
+6% +$34.9K 0.1% 175
2015
Q1 		$607K Buy
3,520
+139
+4% +$21.2K 0.1% 146
2014
Q4 		$438K Buy
+3,381
New +$436K 0.08% 151

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Frontier Wealth Management's UTHR Position: Q4 2019 in Review

Frontier Wealth Management sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 2,650 shares — an estimated $211K sold.

Frontier Wealth Management first reported a position in UTHR in Q4 2014 and held it in 19 quarters. The position peaked at $646K in Q2 2015. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Frontier Wealth Management reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Frontier Wealth Management sold 2,650 United Therapeutics shares in Q4 2019, an estimated $211K.
  • Frontier Wealth Management first reported a position in United Therapeutics in Q4 2014 and held it in 19 quarters.
  • Frontier Wealth Management's United Therapeutics position peaked at $646K in Q2 2015.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Frontier Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.